Physician profile
Jawad Chohan
NPI 1922531441
$4,352.23
in general payments reported to CMS, 2019-2025
7 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.14 · 2021: $16.23 · 2022: $21.40 · 2023: $2,699 · 2024: $1,116 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,600.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $603.48 | 2024-2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $405.20 | 2024-2025 | Cardiomems, Mitraclip |
| Cardiva Medical, INC. | $176.13 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Angiodynamics, INC. | $149.99 | 2024-2025 | Alphavac |
| Teleflex LLC | $136.11 | 2024 | Guideliner |
| Boston Scientific Corporation | $123.14 | 2024 | Rotapro, Comet |
| Cvrx, INC. | $6.74 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jawad Chohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.